Core Molecular Specs & Technical Index

The IGF1 peptide, or Insulin-like Growth Factor 1, is a 70-amino acid single-chain polypeptide with a molecular weight of approximately 7.6 kDa. It is structurally homologous to proinsulin and plays a critical role in cellular growth, differentiation, and metabolic regulation. For B2B buyers, understanding the technical specifications is essential for ensuring product consistency and performance in research and formulation.

• Purity Standard: High-grade IGF1 peptide is typically offered at ≥98% purity as verified by HPLC analysis, with premium recombinant variants reaching ≥99% for advanced research applications.
• Solubility Profile: The peptide is readily soluble in sterile water or dilute acetic acid at concentrations up to 1 mg/mL, with optimal reconstitution at pH 2-3 for maximum stability.
• Storage Requirements: Lyophilized IGF1 peptide must be stored at -20°C or below, with a shelf life of 24-36 months when protected from moisture and light. Reconstituted solutions should be used within 14 days at 4°C.
• Bioactivity Assay: Each batch is tested for cell proliferation activity using MCF-7 or L6 cell lines, with a defined ED50 value typically ranging from 0.5-2 ng/mL to confirm functional integrity.
• Endotoxin Levels: For research and cosmetic applications, endotoxin levels are maintained below 0.1 EU/μg, ensuring compatibility with sensitive cell-based assays and formulation systems.

Industry data from the 2025 Peptide Therapeutics Report indicates that IGF1 peptide demand in regenerative medicine and anti-aging research has grown by 18% year-over-year, with synthetic and recombinant variants accounting for 72% of total market volume. Purity specifications above 98% are now the baseline for professional buyers.

Manufacturing & Quality Control

IGF1 peptide production involves either solid-phase peptide synthesis (SPPS) for synthetic variants or recombinant DNA technology using E. coli or yeast expression systems. The recombinant approach offers superior folding and disulfide bond formation, critical for bioactivity. Quality control protocols include multiple orthogonal methods to ensure batch-to-batch consistency.

• Production Process: SPPS uses Fmoc chemistry with stepwise amino acid coupling, while recombinant methods involve fermentation, cell lysis, and chromatographic purification. Both routes require final lyophilization under controlled conditions.
• Purification Techniques: Reverse-phase HPLC and ion-exchange chromatography are standard, achieving >98% purity. Size-exclusion chromatography removes aggregates, ensuring monomeric peptide for optimal performance.
• Third-Party Testing: Independent laboratories verify peptide identity via mass spectrometry (MS), amino acid analysis, and peptide mapping. Certificate of Analysis (CoA) includes purity, bioactivity, and endotoxin data.
• Certification List: GMP compliance for pharmaceutical-grade products, ISO 9001 for quality management, and ISO 13485 for medical device raw materials. Cosmetic-grade variants may follow INCI standards.

Commercial Application Scenarios

IGF1 peptide serves diverse B2B markets, from cosmetic formulation to advanced laboratory research. Its ability to modulate cellular signaling pathways makes it a versatile ingredient for anti-aging and regenerative product lines. Bulk buyers include contract manufacturers, research institutions, and cosmetic brands seeking high-purity raw materials.

• Cosmetic Formulation: Incorporated into serums and creams at 0.01-0.1% concentrations, IGF1 peptide supports collagen synthesis and skin rejuvenation. It is often combined with copper peptides or growth factors for synergistic effects in premium anti-aging lines.
• Lab Research: Used in cell culture studies to investigate muscle hypertrophy, neuroprotection, and metabolic regulation. Researchers require consistent bioactivity and low endotoxin levels for reproducible results in primary cell lines.
• Bulk Wholesale Usage: Distributors supply IGF1 peptide in multi-gram quantities to pharmaceutical and biotech firms for preclinical studies. Custom packaging in argon-filled vials ensures stability during transit and long-term storage.

igf1 peptide VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

Buyers often encounter pitfalls when sourcing IGF1 peptide, including mislabeled purity, inadequate documentation, and inconsistent bioactivity. A systematic approach to vendor evaluation and product verification is essential for maintaining quality standards in research and commercial applications.

• Common Pitfalls: Low-cost suppliers may offer peptides with truncated sequences or incorrect disulfide bridges. Always request CoA and MS data. Avoid vendors without third-party testing or those offering "research grade" without defined specifications.
• Selection Standards: Prioritize suppliers with GMP or ISO certification. Verify purity via HPLC chromatogram and bioactivity via cell-based assay. For cosmetic use, confirm INCI compliance and stability in formulation vehicles.
• Buyer Checklist: Request batch-specific CoA, check endotoxin levels, confirm storage conditions, evaluate lead times, and ask for stability data under accelerated conditions. Always order a small sample for in-house validation before bulk commitment.

Core Product Advantages

Our IGF1 peptide is manufactured under strict GMP guidelines with a focus on purity, stability, and cost performance. Each batch undergoes rigorous quality control to meet the demands of professional B2B buyers, from cosmetic formulators to research laboratories.

• Purity: Consistently ≥98% as verified by HPLC and mass spectrometry, with minimal aggregation or degradation products. This ensures reliable performance in sensitive applications.
• Stability: Lyophilized formulation with argon gas protection extends shelf life to 36 months at -20°C. Reconstituted solutions remain stable for 14 days at 4°C without significant loss of activity.
• Cost Performance: Competitive pricing for bulk orders (1g, 5g, 10g) with volume discounts up to 30%. Our direct-from-manufacturer model eliminates intermediary markups.
• Technical Support: Dedicated team provides formulation guidance, stability testing protocols, and regulatory documentation. Custom packaging and labeling available for private label clients.

Frequently Asked Questions

Q: What is the difference between synthetic and recombinant IGF1 peptide for B2B buyers?
A: Synthetic IGF1 peptide is produced via solid-phase peptide synthesis and is suitable for cosmetic applications where cost is a primary concern. Recombinant IGF1 peptide, expressed in E. coli or yeast, offers superior folding and disulfide bond formation, resulting in higher bioactivity and consistency. For research applications requiring precise cellular responses, recombinant variants are preferred. Both types can achieve ≥98% purity, but recombinant versions typically have lower endotoxin levels and better batch-to-batch reproducibility.

Q: How should IGF1 peptide be stored and handled in bulk quantities?
A: Lyophilized IGF1 peptide should be stored at -20°C or below in airtight, light-resistant containers. For bulk orders, we recommend dividing into smaller aliquots under inert gas (argon or nitrogen) to minimize freeze-thaw cycles. Reconstitution should be performed using sterile water or dilute acetic acid (pH 2-3) at 4°C, with gentle swirling to avoid foaming. Reconstituted solutions should be used within 14 days when stored at 4°C, or aliquoted and frozen at -20°C for longer storage. Always avoid repeated freeze-thaw cycles to maintain bioactivity.

Q: What documentation should I request when sourcing IGF1 peptide for regulatory compliance?
A: For regulatory compliance, request a Certificate of Analysis (CoA) that includes HPLC purity, mass spectrometry confirmation, amino acid analysis, bioactivity assay (ED50), and endotoxin levels. Additionally, ask for a Certificate of Origin, GMP certificate (if applicable), and stability data under recommended storage conditions. For cosmetic applications, ensure the supplier provides INCI name and safety data sheet (SDS). For research use, a material safety data sheet (MSDS) and batch-specific analytical data are essential. Third-party testing reports from accredited laboratories add an extra layer of verification.

Introduction

IGF1 peptide, or Insulin-like Growth Factor 1, is a recombinant peptide widely recognized in the B2B raw material sector for its role in cellular signaling and metabolic regulation. This 70-amino-acid single-chain polypeptide is primarily sourced by cosmetic formulation labs, research institutions, and bulk peptide distributors seeking high-purity active ingredients for advanced topical and experimental applications. The core value of IGF1 peptide lies in its ability to support dermal matrix maintenance and cellular homeostasis in controlled laboratory settings, making it a cornerstone ingredient for next-generation cosmetic and research-grade formulations.

Core Molecular Specs & Technical Index

Understanding the precise molecular specifications of IGF1 peptide is critical for lab formulation success. The peptide must meet stringent technical indices to ensure batch-to-batch consistency and functional integrity in downstream applications.

Basic Properties

IGF1 peptide is a recombinant human protein with a molecular weight of approximately 7.6 kDa. It is supplied as a lyophilized powder, typically white to off-white in color, and is highly soluble in sterile water or dilute acetic acid. The isoelectric point (pI) is around 8.4, which influences its behavior in buffer systems during formulation.

Purity Specifications

High-grade IGF1 peptide for lab use must exhibit a purity of ≥98% as determined by HPLC analysis. This ensures minimal contamination from truncated sequences or oxidation byproducts, which can compromise experimental reproducibility and product stability.

Solubility & Reconstitution

The peptide is readily soluble in 0.1% acetic acid or sterile water at concentrations up to 1 mg/mL. For cosmetic formulations, it is often pre-dissolved in a buffered solution to maintain pH stability between 5.0 and 6.5, preventing aggregation and preserving bioactivity.

Storage Requirements

Lyophilized IGF1 peptide must be stored at -20°C or below, protected from light and moisture. Once reconstituted, it should be used within 7 days when refrigerated at 2-8°C, or aliquoted and frozen at -20°C for long-term storage to avoid freeze-thaw cycles.

Technical Index List

• Purity: ≥98% by RP-HPLC, with single peak confirmation
• Endotoxin Level: <1.0 EU/mg, suitable for cell culture and lab use
• Biological Activity: Verified by cell proliferation assay (MCF-7 cells)
• Appearance: White lyophilized powder, free of visible aggregates
• Reconstitution: Clear solution at 1 mg/mL in 0.1% acetic acid

Industry data from the Peptide Therapeutics Foundation indicates that over 85% of lab-formulation failures are linked to substandard purity or improper storage of raw peptides, emphasizing the need for certified IGF1 peptide sourcing.

Manufacturing & Quality Control

The production of IGF1 peptide involves a multi-step process that demands rigorous quality control at every stage. From solid-phase synthesis to final lyophilization, each step is monitored to ensure the peptide meets the highest standards for lab and cosmetic use.

Production Process

IGF1 peptide is manufactured using solid-phase peptide synthesis (SPPS) with Fmoc chemistry, followed by cleavage and deprotection. The crude peptide is then purified via preparative HPLC to achieve the target purity level. This process is scalable for bulk orders while maintaining consistency across batches.

Purification & Analysis

After synthesis, the peptide undergoes reverse-phase HPLC purification to remove impurities. Each batch is analyzed using mass spectrometry (MS) for molecular weight confirmation and HPLC for purity verification. Additional tests include amino acid analysis and peptide content determination.

Third-Party Testing

All IGF1 peptide lots are sent to independent laboratories for third-party certification. This includes endotoxin testing, sterility testing, and bioactivity assays. Certificates of Analysis (CoA) are provided with every shipment, detailing all quality parameters.

Certification List

• ISO 9001:2015 – Quality management system certification
• GMP Compliance – Good Manufacturing Practice for pharmaceutical intermediates
• MSDS – Material Safety Data Sheet for safe handling
• CoA – Certificate of Analysis with batch-specific data
• Stability Data – Accelerated and long-term stability reports available

Commercial Application Scenarios

IGF1 peptide is utilized across multiple commercial sectors, each requiring specific handling and formulation protocols. Below are the primary application scenarios for B2B buyers.

Cosmetic Formulation

In cosmetic labs, IGF1 peptide is incorporated into anti-aging serums, creams, and masks at concentrations ranging from 0.01% to 0.1%. It is often combined with other peptides and antioxidants to support dermal matrix maintenance. Formulators must ensure the peptide is stabilized in a buffered system to prevent degradation during shelf life.

Lab Research

Research institutions use IGF1 peptide for cell culture studies, particularly in fibroblast and keratinocyte models. It is added to serum-free media at concentrations of 10-100 ng/mL to study cellular proliferation and differentiation pathways. Purity and bioactivity are paramount for reproducible results.

Bulk Wholesale Usage

Bulk buyers, such as peptide distributors and contract manufacturers, purchase IGF1 peptide in quantities ranging from 1 gram to 1 kilogram. They require consistent batch quality, detailed documentation, and reliable supply chains to meet their clients' demands. Custom packaging and labeling are often requested.

igf1 peptide VS Ordinary Low-Grade Peptides

When sourcing IGF1 peptide, it is essential to distinguish between high-grade material and low-grade alternatives that may compromise formulation integrity. The table below highlights key differences.

Bulk Purchase Selection Guide

Selecting the right IGF1 peptide supplier requires careful evaluation of several factors. Common pitfalls include low purity, inadequate documentation, and unstable supply chains. Follow this guide to make an informed decision.

Common Pitfalls

Buyers often fall for low prices that reflect poor manufacturing standards. Peptides with purity below 95% may contain truncated sequences that alter biological activity. Additionally, suppliers without third-party testing may provide inconsistent batches, leading to formulation failures.

Selection Standards

Always request a Certificate of Analysis (CoA) for each batch. Verify that the purity is ≥98% by HPLC and that endotoxin levels are below 1.0 EU/mg. Check for stability data and ensure the supplier offers GMP-compliant manufacturing. Reliable suppliers provide transparent communication and sample testing options.

Buyer Checklist

• Request CoA – Confirm purity, endotoxin, and bioactivity data
• Verify Certifications – Look for ISO 9001 and GMP compliance
• Test Samples – Order a small batch for in-house validation
• Check Supply Chain – Ensure consistent stock and lead times
• Review Packaging – Confirm lyophilized form and storage instructions

Core Product Advantages

Our IGF1 peptide offers distinct advantages that make it the preferred choice for lab formulation and cosmetic development. These benefits are backed by rigorous manufacturing and quality assurance protocols.

Purity & Consistency

With a guaranteed purity of ≥98% by HPLC, our IGF1 peptide minimizes batch-to-batch variability. This consistency is critical for reproducible results in research and stable formulations in cosmetics. Each batch is tested for single-peak confirmation, ensuring no degradation products are present.

Stability & Shelf Life

Our lyophilized IGF1 peptide maintains stability for up to 24 months when stored at -20°C. Accelerated stability studies show no significant loss of purity or bioactivity under recommended conditions. This long shelf life reduces waste and ensures reliable supply for bulk buyers.

Cost Performance & Technical Support

We offer competitive pricing for bulk orders without compromising quality. Our technical team provides formulation guidance, reconstitution protocols, and stability data to support your product development. This combination of high purity, proven stability, and expert support delivers exceptional value for B2B clients.

Frequently Asked Questions

Q1: What is the recommended storage condition for IGF1 peptide after reconstitution?
After reconstitution, IGF1 peptide should be stored at 2-8°C and used within 7 days. For longer storage, aliquot the solution and freeze at -20°C, avoiding repeated freeze-thaw cycles to maintain bioactivity.

Q2: How do I verify the purity of IGF1 peptide from a supplier?
Request a Certificate of Analysis (CoA) that includes HPLC chromatogram data showing a single peak at the expected retention time. The purity should be stated as ≥98%. Third-party testing reports provide additional verification.

Q3: Can IGF1 peptide be used in cosmetic formulations without additional stabilizers?
While IGF1 peptide can be added directly to formulations, it is recommended to use a buffered system (pH 5.0-6.5) and include antioxidants to prevent oxidation. Stabilizers like trehalose or cyclodextrins can further enhance shelf life.